World Bulletin / News Desk
Women who have migraines may have no greater risk of becoming overweight than other women, despite what some research has suggested, according to an international study.
Some studies have found a connection between excess weight and a higher rate of migraines, but they have mainly studied people at one point in time, leaving unclear whether the weight or the migraines came first.
The current study, which appeared in the journal Cephalalgia, looked at data from the Women's Health Study, a long-term clinical trial that began following thousands of U.S. women in the mid-1990s.
"Our study should be reassuring that having migraine is not associated with future increase in relative body weight or obesity," researcher Tobias Kurth, of the French national research institute INSERM and the University of Bordeaux, said by email.
Overall, women who had migraines at the outset were no more likely than other women to become overweight or obese over the next 13 years. The average weight gain in both groups was almost identical, at around 4.5 kg (10 lb).
In theory, migraines could contribute to weight gain indirectly, such as frequent or severe headaches keeping a person from regular exercise.
The new findings are based on 19,162 female health professionals who were aged 45 or older, and of normal weight, when they entered the study. Almost 3,500 reported a history of migraines.
Over the next 13 years, 41 percent of those women became overweight, while about 4 percent became obese. But the odds of becoming obese were no greater among women with a history of migraine, and the risk of becoming overweight was only slightly higher -- 11 percent.
Severe migraines did not appear to carry a risk of extra weight either, Kurth's team found. Women who had migraines weekly to daily were at no greater risk of becoming overweight or obese than those whose migraines came a few times a year.
The study did not look at whether overweight or obese women are at increased risk of migraines or more severe ones.
"That is still possible. In fact, several studies have now shown that obesity is associated with increased migraine frequency," Kurth said.
There is also some evidence tying obesity to an elevated risk of developing migraines in the first place, but the prevalence of migraine has remained stable in recent decades, while obesity rates have soared, he added.
The World Health Organization has announced that the Ebola virus has killed some 1,552 people in West Africa, mostly in Liberia, Guinea and Sierra Leone, since the outbreak began in January.
UN deputy secretary general Jan Eliasson said the failure to address the issue of sanitation would prove “disastrous.”
The Ebola outbreak in West Africa has taken 1,552 lives out of 3,069 known cases in four countries and "continues to accelerate", WHO said
Presidential Press Secretary Jerolinmek Piah told AA the names would be announced later.
The WHO urged a range of "regulatory options", including prohibiting e-cigarette makers from making health claims
The doctor died after receiving the experimental drug ZMapp.
Japan has received inquiries from some countries on the influenza drug favipiravir, or T-705 as it is known in the developmental code.
Some 54 people have died in or near the capital Accra, and around 300 people are now being infected daily with the highly contagious disease, putting pressure on local health facilities, said Linda Van-Otoo, GHS director for Greater Accra.
A Philippine seaman is being monitored in Togo for signs of the disease but authorities say the country is still Ebola-free, despite dozens of workers returning from Liberia.
A 36-year-old man from Senegal is being tested in Barcelona.
MSF (Doctors Without Borders) has deployed 1,000 of its own staff in the stricken region, running centres that currently have 300 beds
On Wednesday, the residents of the two communities woke up just after the president ordered the quarantine only to find their community barricaded with soldiers and police officers preventing people from leaving or entering the two areas.
They were given ZMapp, a drug used on a handful of patients in the West African outbreak and produced by U.S.-based Mapp Biopharmaceutical.
A local priest who asked not to be named said that the illness had affected several villages and estimated that the death toll was over 100 people.
The calculation highlights the dilemma facing officials considering how to distribute the tiny quantities of unproven drugs that are likely to be available in the near term
"We are hopeful and grateful to God and to the medical team that they are showing signs of improvement," Liberia's Information Minister Lewis Brown told a press conference on Tuesday.